Cantourage, Cannabis House And Together Pharma Partner To Increase Availability Of Medical Cannabis In Poland

Cantourage Group SE HIGH, Cannabis House and Together Pharma TGTR announced a partnership that makes Ugandan medical cannabis available in Poland for the first time. From the first week of December, Polish patients enrolled in the Cannabis House initiative will have access to Together Pharma's Glueberry OG cultivar, which will be distributed via selected pharmacies across the country. After Germany and the UK, Poland marks the third European market in which the product will now be available.

The supply agreement includes the importation of more than 500 kg of finished dried cannabis flowers over the upcoming three years. More products, already offered by Cantourage in the UK and Germany, will be introduced to the initiative in Poland in the coming months.

Philip Schetter, CEO of Cantourage, stated: "We are excited to join forces with Cannabis House and Together Pharma to expand access to medical cannabis products for patients in Poland. We feel privileged to play a part in supplying Polish patients with high quality cannabis from Uganda and in time, broadening the portfolio of products available."

Dr. Grzegorz Kobyłecki, CEO of Cannabis House, stated: "Today, demand for medical cannabis in Poland is at an all-time high. The cannabis market in Poland has quadrupled over the last three years. Therefore, our partnership is an important step in ensuring that enough quality products will be available to patients. It should be emphasized that the experiment is not a clinical trial, but an initiative which holds bio-ethics approval. Given that cannabis from an unknown source could potentially contain mixtures of dangerous and addictive substances, we are proud to partner with companies such as Cantourage, who support us with high quality research material. Furthermore, given that the experiment has a three-year duration, we have worked hard to partner with groups with a stable market position."

Nir Sosinsky, managing director of Together Pharma, stated: "Our partnership with Cantourage continues to flourish and this latest development is extremely exciting for Together Pharma. The export of our products to Poland represents a new stage in the expansion of our global reach and strengthens our position in Europe, which is an important market for us. We are glad that our medical-grade cannabis flowers are being made available through Cantourage and Cannabis House in Poland, allowing for a sustainable supply to the benefit of patients across the country."

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo: Benzinga; Sources: courtesy of jarmoluk and lindsayfox via Pixabay

Related News

Germany's First Cannabis Start-Up Lists On Frankfurt Stock Exchange Ahead Of Legalization

Cantourage Receives Licenses To Import And Prescribe Medical Cannabis In UK

Cantourage Teams Up With Israel's Together Pharma To Bring First Ugandan Medical Cannabis To Germany

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsCannabis HouseCantourageDr. Grzegorz KobyłeckiNir SosinskyPhilip SchetterpremiumTogether Pharma
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.